Hong‐May Sim

684 total citations
14 papers, 566 citations indexed

About

Hong‐May Sim is a scholar working on Oncology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Hong‐May Sim has authored 14 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 5 papers in Infectious Diseases and 5 papers in Molecular Biology. Recurrent topics in Hong‐May Sim's work include Drug Transport and Resistance Mechanisms (12 papers), HIV/AIDS drug development and treatment (5 papers) and Metal complexes synthesis and properties (3 papers). Hong‐May Sim is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), HIV/AIDS drug development and treatment (5 papers) and Metal complexes synthesis and properties (3 papers). Hong‐May Sim collaborates with scholars based in United States, Singapore and Taiwan. Hong‐May Sim's co-authors include Suresh V. Ambudkar, Eduardo E. Chufán, Suneet Shukla, Haneen Amawi, Amit K. Tiwari, Mei‐Lin Go, Pui Lai Rachel Ee, Chong Yew Lee, Chung‐Pu Wu and Sung-Han Hsiao and has published in prestigious journals such as Biochemistry, Cancer Research and Biophysical Journal.

In The Last Decade

Hong‐May Sim

14 papers receiving 556 citations

Peers

Hong‐May Sim
Yu-Shan Wu Taiwan
Clara Lemos Netherlands
G. Simone Italy
Nóra Kucsma Hungary
Hong‐May Sim
Citations per year, relative to Hong‐May Sim Hong‐May Sim (= 1×) peers Ioana Abraham

Countries citing papers authored by Hong‐May Sim

Since Specialization
Citations

This map shows the geographic impact of Hong‐May Sim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐May Sim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐May Sim more than expected).

Fields of papers citing papers by Hong‐May Sim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong‐May Sim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐May Sim. The network helps show where Hong‐May Sim may publish in the future.

Co-authorship network of co-authors of Hong‐May Sim

This figure shows the co-authorship network connecting the top 25 collaborators of Hong‐May Sim. A scholar is included among the top collaborators of Hong‐May Sim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong‐May Sim. Hong‐May Sim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Amawi, Haneen, Hong‐May Sim, Amit K. Tiwari, Suresh V. Ambudkar, & Suneet Shukla. (2019). ABC Transporter-Mediated Multidrug-Resistant Cancer. Advances in experimental medicine and biology. 1141. 549–580. 192 indexed citations
2.
Chufán, Eduardo E., Hong‐May Sim, & Suresh V. Ambudkar. (2015). Molecular Basis of the Polyspecificity of P-Glycoprotein (ABCB1). Advances in cancer research. 125. 71–96. 110 indexed citations
3.
Wang, De‐Shen, Atish Patel, Hong‐May Sim, et al.. (2014). ARRY‐334543 Reverses Multidrug Resistance by Antagonizing the Activity of ATP‐Binding Cassette Subfamily G Member 2. Journal of Cellular Biochemistry. 115(8). 1381–1391. 17 indexed citations
4.
Wu, Chung‐Pu, Hong‐May Sim, & Suresh V. Ambudkar. (2014). Abstract 766: Human ABCB1 and ABCG2 confer acquired resistance to Polo-like kinase 1 inhibitors, BI 2536, volasertib and GSK641364. Cancer Research. 74(19_Supplement). 766–766. 1 indexed citations
5.
Wu, Chung‐Pu, Sung-Han Hsiao, Hong‐May Sim, et al.. (2013). Human ABCB1 (P-glycoprotein) and ABCG2 mediate resistance to BI 2536, a potent and selective inhibitor of Polo-like kinase 1. Biochemical Pharmacology. 86(7). 904–913. 29 indexed citations
6.
Chufán, Eduardo E., et al.. (2013). Chemical Flexibility of P-Glycoprotein for Interaction with Substrates and Modulators. Biophysical Journal. 104(2). 200a–200a. 1 indexed citations
7.
Wu, Chung‐Pu, Hong‐May Sim, Yang-Hui Huang, et al.. (2013). Abstract 3398: Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cells.. Cancer Research. 73(8_Supplement). 3398–3398. 1 indexed citations
8.
Sim, Hong‐May, Jaya Bhatnagar, Eduardo E. Chufán, Khyati Kapoor, & Suresh V. Ambudkar. (2013). Conserved Walker A Cysteines 431 and 1074 in Human P-Glycoprotein Are Accessible to Thiol-Specific Agents in the Apo and ADP-Vanadate Trapped Conformations. Biochemistry. 52(41). 7327–7338. 9 indexed citations
9.
Wu, Chung‐Pu, Hong‐May Sim, Yang-Hui Huang, et al.. (2012). Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cells. Biochemical Pharmacology. 85(3). 325–334. 58 indexed citations
10.
He, Jie‐Hua, Xiao‐Dong Su, Hong‐May Sim, et al.. (2012). Saracatinib (AZD0530) is a potent modulator of ABCB1‐mediated multidrug resistancein vitroandin vivo. International Journal of Cancer. 132(1). 224–235. 35 indexed citations
11.
Bhatnagar, Jaya, Hong‐May Sim, Elka R. Georgieva, et al.. (2012). Mapping Conformational Changes Associated with the Catalytic Cycle of Human P-Glycoprotein (ABCB1). Biophysical Journal. 102(3). 606a–607a. 1 indexed citations
12.
Ma, Xiang, et al.. (2011). Synthesis and antimicrobial activity of N1-benzyl or N1-benzyloxy-1,6-dihydro-1,3,5-triazine-2,4-diamines. Bioorganic & Medicinal Chemistry Letters. 21(18). 5428–5431. 26 indexed citations
13.
Sim, Hong‐May, Chung‐Pu Wu, Suresh V. Ambudkar, & Mei‐Lin Go. (2011). In vitro and in vivo modulation of ABCG2 by functionalized aurones and structurally related analogs. Biochemical Pharmacology. 82(11). 1562–1571. 17 indexed citations
14.
Sim, Hong‐May, Chong Yew Lee, Pui Lai Rachel Ee, & Mei‐Lin Go. (2008). Dimethoxyaurones: Potent inhibitors of ABCG2 (breast cancer resistance protein). European Journal of Pharmaceutical Sciences. 35(4). 293–306. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026